KBS India

Why is KBS India Ltd falling/rising?

As of 09-Jun, KBS India Ltd's stock price is rising to 1.34, reflecting a 2.29% increase, but it has significant declines over the year, with a -25.14% drop year-to-date and -77.85% over the past year. Despite today's rise, investor participation is down, indicating caution amid ongoing volatility.

As of 09-Jun, KBS India Ltd's stock price is rising, currently at 1.34, which reflects a change of 0.03 or 2.29% increase. This upward movement can be attributed to the stock outperforming its sector by 1.41% today. Additionally, the stock has shown a positive performance over the past week, with a return of +5.51%, while the benchmark Sensex has declined by -0.98% during the same period. <BR><BR>Despite this recent rise, it is important to note that the stock has experienced significant declines over longer periods, with a year-to-date drop of -25.14% and a staggering -77.85% over the past year. Furthermore, while the stock is currently trading above its 5-day, 20-day, 50-day, and 100-day moving averages, it remains below its 200-day moving average, indicating mixed signals regarding its longer-term performance.<BR><BR>Investor participation has decreased, as evidenced by a delivery volume of 40.4k on June 8, which is down by -15.78% compared to the 5-day average. This decline in participation may suggest caution among investors despite the recent price increase. Overall, while KBS India Ltd is experiencing a rise in its stock price today, the broader context reveals ongoing challenges and volatility in its performance.

Which are the latest news on KBS India?

Should I buy, sell or hold KBS India Ltd?

When is the next results date for KBS India Ltd?

The next results date for KBS India Ltd is 30 May 2026.

The next results date for KBS India Ltd is scheduled for 30 May 2026.

Are KBS India Ltd latest results good or bad?

KBS India Ltd's latest results are poor, with a 6.90% decline in net sales and a staggering 1,300% drop in net profit compared to the previous year. The company faces significant operational inefficiencies, reflected in a negative operating profit margin of -48.15%, raising concerns about its future viability.

KBS India Ltd's latest results indicate significant challenges and poor performance. In the quarter ending December 2025, the company reported a year-over-year decline in net sales of 6.90%, contrasting sharply with a previous growth of 93.33% in December 2024. This downward trend is further reflected in the standalone net profit, which saw a staggering decline of 1,300% compared to the same quarter last year.<BR><BR>The operational metrics reveal a concerning picture: the operating profit margin remains deeply negative at -48.15%, indicating ongoing operational inefficiencies. Overall, the company continues to struggle with minimal revenue generation, and its financial performance has been characterized by stagnation and losses.<BR><BR>Given these results, KBS India Ltd's performance can be classified as poor, raising serious questions about its business viability and future prospects. Investors should be cautious, as the company has shown no signs of recovery or operational improvement.

Is KBS India overvalued or undervalued?

As of November 10, 2025, KBS India is fairly valued with a PE ratio of 52.40, but has underperformed significantly with a year-to-date return of -79.89%, raising caution for potential investors despite its valuation compared to peers.

As of 10 November 2025, KBS India has moved from an expensive to a fair valuation grade. The company is currently fairly valued, with a PE ratio of 52.40, an EV to EBIT ratio of 48.29, and a Price to Book Value of 0.06. In comparison to its peers, Bajaj Finance is considered very expensive with a PE ratio of 38.76, while Life Insurance stands out as very attractive with a PE ratio of 11.14, indicating a significant disparity in valuation within the sector.<BR><BR>Despite KBS India's fair valuation, its performance has been notably poor, with a year-to-date return of -79.89%, contrasting sharply with the Sensex's positive return of 6.91% over the same period. This underperformance, coupled with a negative capital employed impacting ROCE, suggests caution for potential investors.

How has been the historical performance of KBS India?

KBS India has shown fluctuating net sales, increasing from 0.76 Cr in Mar'19 to 2.37 Cr in Mar'25, while total expenditure peaked at 3.12 Cr in Mar'24. Despite recent losses, the company reported a profit before tax of 0.46 Cr in Mar'25, indicating a positive trend in profitability.

Answer:<BR>The historical performance of KBS India shows a fluctuating trend in net sales and profitability over the years, with a notable increase in net sales in the latest fiscal year.<BR><BR>Breakdown:<BR>KBS India has experienced a steady increase in net sales, rising from 0.76 Cr in Mar'19 to 2.37 Cr in Mar'25. However, total expenditure has also increased, peaking at 3.12 Cr in Mar'24 before slightly decreasing to 2.91 Cr in Mar'25. This has resulted in operating profit (PBDIT) remaining negative in recent years, with a loss of 0.54 Cr in Mar'25 compared to a loss of 1.38 Cr in Mar'24. Despite these challenges, the company reported a profit before tax of 0.46 Cr in Mar'25, up from 0.06 Cr in Mar'24, and a profit after tax of 0.18 Cr, indicating a positive trend in profitability. The earnings per share (EPS) have fluctuated, reaching 0.02 in Mar'25, consistent with the previous year. The company's total assets have decreased from 27.50 Cr in Mar'19 to 26.42 Cr in Mar'21, while total liabilities have also decreased, indicating a stable financial position. Overall, KBS India shows signs of recovery in profitability despite ongoing challenges in managing expenditures.

How big is KBS India?

As of 24th July, KBS India Ltd has a market capitalization of 54.00 Cr, classifying it as a Micro Cap company, with recent Net Sales of 0.42 Cr and a Net Profit of 0.97 Cr. The company has Shareholder's Funds of 25.16 Cr and Total Assets of 26.42 Cr.

As of 24th July, KBS India Ltd has a market capitalization of 54.00 Cr, which classifies it as a Micro Cap company.<BR><BR>For the latest four quarters, KBS India reported Net Sales of 0.42 Cr and a Net Profit of 0.97 Cr. The figures reflect the company's performance over the most recent two quarters.<BR><BR>The latest annual period for KBS India shows Shareholder's Funds of 25.16 Cr and Total Assets of 26.42 Cr. These values provide insight into the company's financial standing.

Who are the top shareholders of the KBS India?

The top shareholders of KBS India include Tushar Suresh Shah with 20.42%, Suresh Bachubhai Shah at 10.65%, and individual investors holding 61.27%. There are also 2 Foreign Institutional Investors with 5.68%, and no pledged promoter holdings or mutual fund investments.

The top shareholders of KBS India include Tushar Suresh Shah, who holds the largest stake at 20.42%. The highest public shareholder is Suresh Bachubhai Shah, with a holding of 10.65%. Additionally, individual investors collectively own 61.27% of the company. There are also 2 Foreign Institutional Investors (FIIs) that hold 5.68% of the shares. Notably, there are no pledged promoter holdings and no mutual funds currently invested in the company.

Who are in the management team of KBS India?

As of March 2023, the management team of KBS India includes Tushar Shah (Chairman/Executive Director), Vinod Kumar Bapna, Sanjeevlata Samdani, Namita Shah, and Sushmita Swarup Lunkad, with varying remuneration levels. The team consists of both executive and independent directors.

As of March 2023, the management team of KBS India includes the following individuals:<BR><BR>1. Tushar Shah - Chairman / Executive Director with a remuneration of 24.0 lacs INR.<BR>2. Vinod Kumar Bapna - Independent Non-Executive Director with a remuneration of 1.5 lacs INR.<BR>3. Sanjeevlata Samdani - Independent Non-Executive Director with no remuneration.<BR>4. Namita Shah - Non-Executive Director with no remuneration.<BR>5. Sushmita Swarup Lunkad - Independent Non-Executive Director with no remuneration. <BR><BR>This team comprises a mix of executive and independent directors, contributing to the governance of the company.

What is the technical trend for KBS India?

As of May 16, 2025, KBS India shows a mildly bearish trend with mixed signals from MACD and bearish indicators from moving averages and Bollinger Bands, suggesting caution in the market.

As of 16 May 2025, the technical trend for KBS India has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish, suggesting mixed signals in the longer term. The RSI shows no signal on the weekly chart but is bullish on the monthly, indicating potential strength in the longer time frame. Moving averages on the daily chart are mildly bearish, reinforcing the current cautious outlook. Bollinger Bands are bearish on both weekly and monthly time frames, which adds to the bearish sentiment. The KST is mildly bullish weekly but mildly bearish monthly, indicating a lack of strong momentum. Dow Theory reflects a mildly bearish stance on the weekly chart with no trend on the monthly. Overall, the current technical stance is mildly bearish, driven primarily by the mixed signals from MACD and the bearish indicators from moving averages and Bollinger Bands.

What does KBS India do?

KBS India Ltd is a Micro Cap stock broking and investment company in the NBFC sector, incorporated in 1985. As of March 2025, it reported net sales and profit of 0 Cr, with a market cap of Rs 66 Cr.

Overview:<BR>KBS India Ltd operates as a stock broking and investment company in the Non Banking Financial Company (NBFC) sector and is categorized as a Micro Cap.<BR><BR>History:<BR>KBS India Limited was incorporated in March 1985 and underwent a name change from KBS Capital Management Limited to KBS India Limited on January 11, 2011. The most recent quarterly results reported net sales and net profit of 0 Cr for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 0 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 0 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 66 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 66.00 <BR>Industry P/E: 23 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.00 <BR>Return on Equity: 0.51% <BR>Price-to-Book: 1.98 <BR><BR>Contact Details:<BR>Address: 502 Commerce House, 140 Nagindas Master Rd Fort Mumbai Maharashtra : 400001 <BR>Tel: 91-022-40362626/40362727 <BR>Email: chandu.kbs@outlook.com <BR>Website: http://www.kbs.co.in

Has KBS India declared dividend?

No Dividend History Available

Who are the peers of the KBS India?

KBS India's peers include Bajaj Finance, Jio Financial, Cholaman.Inv.&Fn, Shriram Finance, Muthoot Finance, Elixir Capital, Arunis Abode, Biogen Pharma, and Lak. Fin. & Indl. KBS India has below-average management risk and growth, with a 1-year return of -31.51%, lower than its peers.

Peers: The peers of KBS India are Bajaj Finance, Jio Financial, Cholaman.Inv.&Fn, Shriram Finance, Muthoot Finance, Elixir Capital, Arunis Abode, Biogen Pharma, and Lak. Fin. & Indl.<BR><BR>Quality Snapshot: Excellent management risk is observed at Bajaj Finance, Cholaman.Inv.&Fn, and Muthoot Finance, while Average management risk is found at Jio Financial and Elixir Capital. Good management risk is present at Shriram Finance, and Below Average management risk is noted at Arunis Abode, KBS India, Biogen Pharma, and Lak. Fin. & Indl. Growth is Excellent at Jio Financial and Elixir Capital, Good at Bajaj Finance and Cholaman.Inv.&Fn, Average at Shriram Finance and Arunis Abode, and Below Average at KBS India, Muthoot Finance, Biogen Pharma, and Lak. Fin. & Indl. Capital Structure is Excellent at Bajaj Finance, Shriram Finance, Muthoot Finance, Elixir Capital, and Lak. Fin. & Indl., Good at Cholaman.Inv.&Fn, and Below Average at Arunis Abode, KBS India, and Biogen Pharma.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Arunis Abode at 365.82%, while the lowest is Jio Financial at -20.19%. KBS India's 1-year return is -31.51%, which is lower than both. Additionally, Elixir Capital, KBS India, Biogen Pharma, and Jio Financial have negative six-month returns.